Most obesity drugs do not improve quality of life or heart health, analysis indicates

Medical Xpress

Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence published by The BMJ. ...

전문 보기

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Most obesity drugs do not improve quality of life or heart health, analysis indicates

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Womb fluid infusions help fetuses with kidney failure survive after birth

Catching hydrogen in the act: Tracking the absorption process over time

Alcohol drives opposite brain circuit changes in amyloid and tau Alzheimer's models

Medical Xpress의 다른 기사

Nursing scholar calls for greater recognition of nurses' 'dual expertise'

Gut bacteria linked to malnutrition may pass to younger generations

One-size-fits-all fetal growth charts often fail to spot at-risk babies, large study finds